1. 2019
  2. Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use program

    Joris, S. R., Pieters, T., Sibille, A., Bustin, F., Jacqmin, L., Kalantari, HR., SURMONT, VEERLE., Goeminne, J-C., Clinckart, F., Pat, K., Demey, W., Deschepper, K., Lambrechts, M., Holbrechts, S., Schallier, D. & Decoster, L., 29 Nov 2019, In : J Geriatr Oncol.

    Research output: Contribution to journalArticleResearchpeer-review

  3. The genomic landscape of non-small cell lung carcinoma in never smokers

    Boeckx, B., Bahadur Shahi, R., Smeets, D., De Brakeleer, S., Decoster, L., Van Brussel, T., Galdermans, D., Vercauter, P., Decoster, L., Alexander, P., Berchem, G., Ocak, S., Vuylsteke, P., Deschepper, K., Lambrechts, M., Cappoen, N., Teugels, E., Lambrechts, D. & De Greve, J., 19 Nov 2019, In : International Journal of Cancer.

    Research output: Contribution to journalArticleResearchpeer-review

  4. Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study

    Rogiers, A. I., Leys, C., De Cremer, J., Awada, G., Schembri, A., Theuns, P., De Ridder, M. & Neyns, B., 31 Oct 2019, In : Supportive Care in Cancer. 2019, 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  5. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use

    Lecocq, Q., Zeven, K., De Vlaeminck, Y., Martens, S., Massa, S., Goyvaerts, C., Raes, G., Keyaerts, M., Breckpot, K. & Devoogdt, N., 29 Sep 2019, In : Biomolecules. 9, 10, 20 p., 548.

    Research output: Contribution to journalArticleResearchpeer-review

  6. Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

    Seremet, T., Jansen, Y., Planken, S., Njimi, H., Delaunoy, M., El Housni, H., Awada, G., Schwarze, J. K., Keyaerts, M., Everaert, H., Lienard, D., Del Marmol, V., Heimann, P. & Neyns, B., 5 Sep 2019

    Research output: Other contributionResearch

  7. Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications

    Martens, S., Lefesvre, P., Nicolle, R., Biankin, A. V., Puleo, F., Van Laethem, J-L. & Rooman, I., Sep 2019, In : Annals of Oncology. 30, 9, p. 1428-1436 9 p.

    Research output: Contribution to journalArticleResearchpeer-review

  8. Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review

    de Filette, J. M. K., Pen, J. J., Decoster, L., Vissers, T., Bravenboer, B., Van der Auwera, B. J., Gorus, F., Roep, B. O., Aspeslagh, S., Neyns, B., Velkeniers, B. & Kharagjitsingh, A. V., Sep 2019, In : European Journal of Endocrinology. 181, 3, p. 363-374 12 p.

    Research output: Contribution to journalArticleResearchpeer-review

  9. CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition

    Noeparast, A., Giron, P., Noor, A., Bahadur Shahi, R., De Brakeleer, S., Eggermont, C., Vandenplas, H., Boeckx, B., Lambrechts, D., De Grève, J. & Teugels, E., Aug 2019, In : ONCOGENE. 38, 31, p. 5933-5941 9 p.

    Research output: Contribution to journalArticleResearchpeer-review

  10. Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

    Jansen, Y. J. L., Rozeman, E. A., Mason, R., Goldinger, S. M., Foppen, M. H. G., Hoejberg, L., Schmidt, H., van Thienen, J. . V., Haanen, J. B. A. G., Tiainen, L., Svane, I. M., Makela, S., Seremet, T., Arance, A., Dummer, R., Bastholt, L., Nyakas, M., Straume, O., Menzies, A. M., Long, G. . V. & 3 othersAtkinson, V., Blank, C. U. & Neyns, B., Jul 2019, In : Annals of Oncology. 30, 7, p. 1154-1161

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...51 Next

ID: 25692